Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
The Journal of Investigative Dermatology|February 18, 2024
Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1Laura Fertitta, Arnaud Jannic, Ouidad Zehou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit SurveyCandice Lesage, Christine Longvert, Sorilla Prey, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2019
Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2019
Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort studyD Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, et al.European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.The Journal of Investigative Dermatology|January 26, 2018
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched AnalysesFlorence Poizeau, Olivier Gaudin, Laurence Le Cleach, et al.Cancers|April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaDavid Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.The Journal of Pathology|October 24, 2025
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomasCarmen Al Youssef, Mansour Alkobtawi, Rémi Safi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM networkRobin Zagala, Stephane Dalle, Marie Beylot-Barry, et al.The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.Pageof 3